Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial

BACKGROUND: Early and intensive treatment is important to inducing remission and preventing joint damage in patients with rheumatoid arthritis. While intensive combination therapy (Disease Modifying Anti-rheumatic Drugs and/or biologicals) is the most effective, rheumatologists in daily clinical pra...

Descripción completa

Detalles Bibliográficos
Autores principales: Claessen, Susanne JJ, Hazes, Johanna MW, Huisman, Margriet AM, van Zeben, Derkjen, Luime, Jolanda J, Weel, Angelique EAM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702315/
https://www.ncbi.nlm.nih.gov/pubmed/19538718
http://dx.doi.org/10.1186/1471-2474-10-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702315/
https://www.ncbi.nlm.nih.gov/pubmed/19538718
http://dx.doi.org/10.1186/1471-2474-10-71

Ejemplares similares